← Mechanisms of action
Natural killer cell
CELL-LINEHomo sapiens
Drugs acting on this target (32)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| Alpha-galactosylceramide | Immunity, passive | experimental | Small molecule | Natural killer cell immunity, passive |
| idp-023 | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| inkmune | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| m-cenk | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| nkae cells | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| sar445419 | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| sz011 | Immunity, passive | experimental | Cell therapy | Natural killer cell immunity, passive |
| acnk-sup003 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| autologous natural killer cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| cd3-cd56+ natural killer cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| cnk-ut009 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| fate-nk100 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| ft516 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| gic-102 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| gt801 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| i15.nkg2d.zeta nk cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| inkt cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| jy306 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| liver nk cell | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| lucar-dks1 nk cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| meta10-til | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| mg4101 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| nk 010 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| nk510 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| nkt cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| onc-plureceptor nk cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| pank-003 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| pnk-007 | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| retronectin active killer cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| SMT-NK | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| tgfβi nk cells | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |
| vgo-cs01p | Supplementation | experimental | Cell therapy | Natural killer cell supplementation |